论文部分内容阅读
目的 :探讨非手术疗法应用药物介入治疗原发性肝癌。方法 :采用肝动脉插管化疗 (HAI) ,肝动脉栓塞术 (HAE)及B超介导下瘤体内注射无水酒精 ,设对照组 ,双介入治疗原发性肝癌。结果 :综合组 (HAE +HAI+B超介导下瘤体内注射无水酒精 )l年生存率 6 1.3 % ,对照组 (单纯HAE +HAI) 1年生存率为 35 .5 % ,两组对比具有显著性差异 (P <0 .0 1)。结论 :双介入治疗原发性肝癌能够提高肝癌患者的 1年生存率及生存质量 ,为肝癌的非手术治疗开辟了新途径。
Objective: To explore non-surgical therapy with drug interventional treatment of primary liver cancer. Methods: Hepatic arterial catheterization chemotherapy (HAI), hepatic artery embolization (HAE) and intratumoral injection of anhydrous alcohol were used in B-ultrasonography. The control group was treated with double interventional treatment of primary liver cancer. Results: The one-year survival rate in the integrated group (HAE + HAI+B-mediated superinjection of anhydrous ethanol) was 61.3%. The 1-year survival rate in the control group (HAE + HAI alone) was 35.5%. There was a significant difference (P < 0.01). Conclusion : Double interventional treatment of primary hepatocellular carcinoma can improve the 1-year survival rate and quality of life of patients with hepatocellular carcinoma and open up new ways for non-surgical treatment of liver cancer.